Skip to content
Research Article Open access CC BY 4.0

Anti-thyroid Antibodies in Patients with HCV Genotype 3a: A Pilot Study

Sana Temuri, Nadeem Afzal, Mohammad Kashif, Ahmed Nadeem, Faheem Shahzad, Waqas Latif, Afia Abbas, Tafazzul H. Mahmud

Microbiology Research Journal International · pp. 1–5 · Published 27 Oct 2016

10.9734/BMRJ/2016/28690

Abstract

Background: Each year, 3 to 4 million people are infected with hepatitis C virus (HCV) and it is the major cause of liver disease worldwide. The patient with acute HCV is often asymptomatic but can present with fatigue and jaundice. About 80% of HCV infected individual’s progress to chronic state. There is an increased prevalence of HCV infection with autoimmune diseases and the most common is chronic thyroiditis, which is an inflammatory disease that leads to hypothyroidism. These individuals have an increased level of antithyroid peroxidase antibody (anti TPO-Ab). Objectives: To determine the prevalence of antithyroid antibody (ATA) in patients of HCV genotype 3a. Materials and Methods: Fifty HCV infected patients with genotype 3a were enrolled in this study that included 33 males and 17 females. After written informed consent, 3 ml blood of all the patients was obtained and ATAs were detected by indirect immunofluorescence technique. These patients were divided into 3 groups, i.e. untreated 26 (52%), mid treated 17 (34%) and 7 (14%) patients with hepatocellular carcinoma (HCC). Results: Among the patients 17(51.5%) males and 7 (41.2%) females had ATA. Regarding different groups, 19 (73.1%) of untreated, 5 (29.4%) of mid treated and none of the patient in HCC group had ATA. Conclusion: ATA was detected in a high percentage of patients with HCV genotype 3a. These antibodies were significantly higher in untreated patients as compared to mid treated and HCC patients. Further, more males had these antibodies as compared to females.

Autoantibodies Antithyroid antibody ATA HCV genotype 3a

References (13)

  1. 1 Steatosis affects chronic hepatitis C progression in a genotype specific way [DOI]
  2. 2 Thyroid disorders in chronic hepatitis C [DOI]
  3. 3 Increased prevalence of antithyroid antibodies identified in women with recurrent pregnancy loss but not in women undergoing assisted reproduction [DOI]
  4. 4 Hypothyroidism and Thyroiditis [DOI]
  5. 5 Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma [DOI]
  6. 6 High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy [DOI]
  7. 7 Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha [DOI]
  8. 8 Autoimmunity induced by interferon-α therapy for chronic viral hepatitis [DOI]
  9. 9 The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism [DOI]
  10. 10 Long-Term Outcome of Interferon- -Induced Thyroid Autoimmunity and Prognostic Influence of Thyroid Autoantibody Pattern at the End of Treatment [DOI]
  11. 11 Autoimmune thyroid disorders in hepatitis C virus infection: Effect of interferon therapy [DOI]
  12. 12 High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy [DOI]
  13. 13 Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection.

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

51

Page views

0

PDF downloads

6

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.